Literature DB >> 12898451

Infection of placental trophoblasts by Toxoplasma gondii.

Marjan Abbasi1, Kinga Kowalewska-Grochowska, Mohammad A Bahar, Ruhangiz T Kilani, Bonnie Winkler-Lowen, Larry J Guilbert.   

Abstract

How the intracellular parasite Toxoplasma gondii causes placental inflammation and infects the fetus is unknown. By use of a culture model of primary human trophoblasts, we examined the consequences of infection by a virulent strain of T. gondii. Infection fractions (parasitophorous vacuoles per trophoblast nuclei) < or =0.9 were observed 1 day after challenge at an inoculum ratio of T. gondii to nuclei of 10. The culture content of infectious T. gondii increased 45-fold in 48 h. Two days after infection, almost 30% of trophoblast nuclei became apoptotic, and 30%-35% of nuclei were lost. Almost 90% of apoptotic nuclei were not adjacent to a parasitophorous vacuole, suggesting infection protected against apoptosis. However, there was no T. gondii-dependent accumulation of putative cytotoxic factors, such as tumor necrosis factor-alpha, that could mediate paracrine killing. Both mature and immature trophoblasts can be productively infected, and uninfected, but not infected, cells undergo apoptosis.

Entities:  

Mesh:

Year:  2003        PMID: 12898451     DOI: 10.1086/377132

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Pathogens and the placental fortress.

Authors:  Jennifer R Robbins; Anna I Bakardjiev
Journal:  Curr Opin Microbiol       Date:  2011-12-12       Impact factor: 7.934

2.  Tissue barriers of the human placenta to infection with Toxoplasma gondii.

Authors:  Jennifer R Robbins; Varvara B Zeldovich; Anna Poukchanski; John C Boothroyd; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

3.  Evaluation of various methods of maternal placental blood collection for immunology studies.

Authors:  Caroline Othoro; Julie M Moore; Kathleen Wannemuehler; Bernard L Nahlen; Juliana Otieno; Laurence Slutsker; Altaf A Lal; Ya Ping Shi
Journal:  Clin Vaccine Immunol       Date:  2006-05

Review 4.  Concepts and mechanisms: crossing host barriers.

Authors:  Kelly S Doran; Anirban Banerjee; Olivier Disson; Marc Lecuit
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

5.  Invasion of the placenta during murine listeriosis.

Authors:  Alban Le Monnier; Olivier F Join-Lambert; Francis Jaubert; Patrick Berche; Samer Kayal
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Reactive oxygen species-triggered trophoblast apoptosis is initiated by endoplasmic reticulum stress via activation of caspase-12, CHOP, and the JNK pathway in Toxoplasma gondii infection in mice.

Authors:  Xiucai Xu; Tingting Liu; Aimei Zhang; Xingxing Huo; Qingli Luo; Zhaowu Chen; Li Yu; Qing Li; Lili Liu; Zhao-rong Lun; Jilong Shen
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

7.  P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages.

Authors:  Michael P Lees; Stephen J Fuller; Rima McLeod; Nicola R Boulter; Catherine M Miller; Alana M Zakrzewski; Ernest J Mui; William H Witola; Jessica J Coyne; Aubrey C Hargrave; Sarra E Jamieson; Jenefer M Blackwell; James S Wiley; Nicholas C Smith
Journal:  J Immunol       Date:  2010-05-19       Impact factor: 5.422

Review 8.  Parasite dissemination and the pathogenesis of toxoplasmosis.

Authors:  L M Randall; C A Hunter
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 9.  Microbial Vertical Transmission during Human Pregnancy.

Authors:  Nitin Arora; Yoel Sadovsky; Terence S Dermody; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

10.  BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-gamma, interleukin-10 and transforming growth factor-beta1.

Authors:  B F Barbosa; D A O Silva; I N Costa; J R Mineo; E A V Ferro
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.